glaucoma

Cyclophotocoagulation shows safety in glaucoma case seriesCharles L. Harris, MD, reviews safety and efficacy rates in a glaucoma case series after adding a proprietary laser system with probe to the surgical armamentarium.
CO2 laser-assisted procedure showing long-term efficacy, safety
CO2 laser-assisted procedure showing long-term efficacy, safetyCO2 laser-assisted sclerectomy performed with a proprietary laser system is a simplified filtration procedure that is showing good IOP-lowering efficacy and safety in eyes followed to 5 years.
Second pivotal trial confirms IOP-lowering efficacy of first-in-class agentResults from a second pivotal trial investigating latanoprostene bunod 0.024% (LBN) are consistent with another identically designed study showing that not only is LBN non-inferior to timolol maleate 0.5% for lowering IOP, but it has significantly greater efficacy.
Novel gelatin stent works effectively as stand-alone procedureOne-year results are reviewed for use of a novel ab-interno gelatin stent as a stand-alone procedure for patients with mild-to-moderate primary open-angle glaucoma.
New dual blade can help surgeons lower IOPA new trabecular meshwork excision blade takes a new approach in IOP reduction.
Bimatoprost sustained-release implants: Potential new pathway for glaucoma patientsThe bimatoprost sustained-release implant (bimatoprost SR, Allergan) improves compliance for patients with problematic compliance with topical IOP-lowering glaucoma drugs and controlled the IOP for 6 months after injection.
Ceeable aims to be the next gold standard in visual fields
Ceeable aims to be the next gold standard in visual fieldsCeeable, a web-based, mobile digital technology designed to detect early-stage eye diseases—an innovation that can help shape 21st century medicine—was awarded third place in the American Medical Association’s inaugural Healthier Nation Innovation Challenge.
Optometrists should get involved in national politics, says OD RNC speaker
Optometrists should get involved in national politics, says OD RNC speakerAfter speaking at last week’s Republican National Convention in Cleveland, New Mexico OD Lisa Shin says more optometrists should get involved on a national level to keep optometry’s agenda at the forefront.
Check out a recap from the 2016 Glaucoma 360 gala!
Check out a recap from the 2016 Glaucoma 360 gala!From the silent auction, art sales, and an opera performance, the 2016 Glaucoma 360 gala was one not to be soon forgotten.
Santen to acquire InnFocus, developer of glaucoma drainage implantSanten Pharmaceutical will soon acquire InnFocus, developer of a glaucoma implant device (InnFocus Microshunt), for $225 million, according to a definitive agreement from the two companies.